Loading clinical trials...
Loading clinical trials...
A Prospective, Multicenter, Randomized, Rater- and Subject-Blind, Parallel Group Trial to Investigate the Non-Inferiority of NT 201, Free of Complexing Proteins, in Comparison With Clostridium Botulinum Toxin Type A in the Treatment of Glabellar Frown Lines
Conditions
Interventions
NT 201 (IncobotulinumtoxinA (Xeomin®/Bocouture®))
OnabotulinumtoxinA (Vistabel®)
Locations
17
Austria
Baden, Austria
Krems, Austria
Salzburg, Austria
Vienna, Austria
Bad Soden, Germany
Böblingen, Germany
Start Date
November 1, 2008
Primary Completion Date
April 1, 2009
Completion Date
May 1, 2009
Last Updated
March 8, 2012
NCT05481931
NCT06411002
NCT05146999
NCT05148000
NCT05277337
NCT04249583
Lead Sponsor
Merz Pharmaceuticals GmbH
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions